Skip to main navigation Skip to search Skip to main content

Delayed onset of benign pleural effusion following concurrent chemoradiotherapy for inoperable non-small-cell lung cancer

    Research output: Contribution to journalArticlepeer-review

    3 Citations (Scopus)

    Abstract

    Chronic benign pleural effusion (BPE) is a rare complication of concurrent chemoradiotherapy (CRT) for inoperable stage IIIA non-small-cell lung cancer (NSCLC). This report presents three cases of BPE, the workup to differentiate this benign condition from recurrence of cancer and recommends a pleural biopsy as part of the diagnostic process. These inflammatory exudates often remain indolent, and may not require drainage or surgical intervention. In the absence of clinical, radiological and pathological evidence of recurrent disease, we recommend clinicians manage these patients expectantly, using regular clinical assessment and imaging. Internal Medicine Journal

    Original languageEnglish
    Pages (from-to)218-221
    Number of pages4
    JournalInternal Medicine Journal
    Volume45
    Issue number2
    DOIs
    Publication statusPublished - 1 Feb 2015

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • Benign pleural effusion
    • Case series
    • Concurrent chemoradiotherapy
    • Non-small-cell lung cancer
    • Stage III inoperable

    Fingerprint

    Dive into the research topics of 'Delayed onset of benign pleural effusion following concurrent chemoradiotherapy for inoperable non-small-cell lung cancer'. Together they form a unique fingerprint.

    Cite this